# Valence8

Valence8 is a Private Equity based in Cambridge, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Cambridge, United States
- **Region:** North America
- **Address:** Cambridge, MA, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** www.valence8.com
- **LinkedIn:** https://www.linkedin.com/company/valence8

## Regulatory record

- **CRD number:** 317389
- **SEC file number:** 801-122837
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/317389

## About

Valence8 was established in 2021 by John Simons in Cambridge, Massachusetts, positioning itself as a specialist private equity fund-of-funds manager with a distinct hybrid mandate. The firm originates from an academic-adjacent entrepreneurial ecosystem rather than a traditional finance center, a structural choice that may inform its approach to manager selection and network-building. Simons leads the firm's investment strategy, which spans fund commitments, co-investments, and selective direct investments. The firm deploys capital across three primary channels: commitments to private equity and venture capital funds, direct co-investments alongside those managers, and occasional standalone direct investments. Its fund commitment activity covers buyout, growth capital, and venture strategies, while the co-investment and direct programs target diversified industries within the United States. The firm does not publicly disclose specific portfolio holdings, but its strategy implies exposure to a broad cross-section of US-based private companies through its underlying fund relationships. Valence8 operates from a single office in Cambridge, with information on team size and total deployment not publicly disclosed. The firm's structural approach — combining fund-of-funds commitments with a co-investment sleeve — places it in a category of hybrid allocators that aim to capture GP selection alpha while also building direct exposure to specific assets. No adjacent vehicles, philanthropic foundations, or club memberships have been publicly identified as of 2025. A structural differentiator for Valence8 is its launch timing and location. The 2021 vintage placed it at the peak of a frenzied private markets cycle, while its Cambridge base — removed from traditional fund-of-funds hubs in New York, San Francisco, or Greenwich — may offer differentiated access to emerging managers spun out of the Massachusetts innovation corridor's academic and life sciences clusters. The firm's multi-channel investment strategy also departs from the pure fund-of-funds model, introducing a direct investment capability that more closely resembles an outsourced CIO or a limited partner with co-investment discretion.

## Sectors

- Fund of Funds
- Private Equity
- Venture Capital
- Growth Capital
- Buyout

## People

- John C. Simons — Founder & Managing Partner

## Questions

### Who runs investment decisions at Valence8?

John Simons, the founder and managing partner, leads investment decisions at Valence8. The firm's public record identifies no additional named partners or investment committee members. Simons steers the firm's fund commitment, co-investment, and direct investment activity from its Cambridge headquarters.

### What investment stages does Valence8 target?

The firm targets a range of stages through its fund commitments, including buyout, growth capital, and venture capital. Its co-investment and direct investment programs also span these stages, maintaining a diversified approach across the private company lifecycle within the United States.

## Related profiles

- [Valedor Partners](https://altss.com/profile/valedor-partners)
- [Valence Life Sciences](https://altss.com/profile/valence-life-sciences)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/valence8

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology